Trials / Completed
CompletedNCT04085783
PRP in Recurrent Implantation Failure
PRP in Recurrent Implantation Failure , Hope or Hype
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Dr. Kamal Rageh · Academic / Other
- Sex
- Female
- Age
- 22 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The endometrial function and endometrial receptivity have been accepted to be major limiting factors in the establishment of pregnancy. In spite of improved almost all aspects of IVF: ovarian stimulation, embryo culture and transfer, the pregnancy rates still not satisfactory. The bottleneck is the process of implantation. Recurrent implantation failure (RIF) is one of the nightmares in reproductive medicine and despite several strategies that have been described for management; there is no universal agreement yet. Recently, intrauterine infusion of platelet-rich plasma (PRP) is described to promote endometrial growth and receptivity, PRP has been investigated as a therapeutic approach for several medical disorders in dermatology and rheumatology, but its use in IVF is still limited. Objective: To evaluate the effectiveness of intrauterine perfusion of autologous platelet-rich plasma in the improvement of pregnancy rate in RIF patients.
Detailed description
After ethical committee approval was obtained, 150 infertile women with history of RIF gave their written consent to be included in this study. All were recruited from the outpatient clinic of Al-Baraka fertility hospital - with age below 40 yrs, body mass index (BMI) below 30 kg/m2, whose uteri were morphologically normal as confirmed by HSG and U/S to limit additional factors that may affect the results of the study - Divided into 2 comparable groups; all participants underwent antagonist protocol, oocytes retrieval, fertilization and embryo transfer; In the study group, intrauterine infusion of 0.5 to 1 ml of platelet-rich plasma (PRP) was performed 48 hrs before blastocyst transfer, pregnancy tests were done 12 days after ET.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | PRP | Platelet Rich Plasma |
Timeline
- Start date
- 2017-12-03
- Primary completion
- 2018-06-15
- Completion
- 2018-06-15
- First posted
- 2019-09-11
- Last updated
- 2019-09-11
Locations
1 site across 1 country: Bahrain
Source: ClinicalTrials.gov record NCT04085783. Inclusion in this directory is not an endorsement.